From the book reviews: "The target audience ... is primarily researchers in psychopharmacology involved in drug development. ... Each chapter concludes with citations of the pertinent scientific literature. This book covering small molecular therapeutics for schizophrenia would be a useful review for researchers studying this area." (Michael Joel Schrift, Doody's Book Reviews, March, 2015)